These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 22185605)
1. Microscopic binding of M5 muscarinic acetylcholine receptor with antagonists by homology modeling, molecular docking, and molecular dynamics simulation. Huang X; Zheng G; Zhan CG J Phys Chem B; 2012 Jan; 116(1):532-41. PubMed ID: 22185605 [TBL] [Abstract][Full Text] [Related]
2. Novel muscarinic acetylcholine receptor hybrid ligands embedding quinuclidine and 1,4-dioxane fragments. Del Bello F; Bonifazi A; Giorgioni G; Petrelli R; Quaglia W; Altomare A; Falcicchio A; Matucci R; Vistoli G; Piergentili A Eur J Med Chem; 2017 Sep; 137():327-337. PubMed ID: 28609709 [TBL] [Abstract][Full Text] [Related]
3. Discovery, synthesis and characterization of a highly muscarinic acetylcholine receptor (mAChR)-selective M5-orthosteric antagonist, VU0488130 (ML381): a novel molecular probe. Gentry PR; Kokubo M; Bridges TM; Cho HP; Smith E; Chase P; Hodder PS; Utley TJ; Rajapakse A; Byers F; Niswender CM; Morrison RD; Daniels JS; Wood MR; Conn PJ; Lindsley CW ChemMedChem; 2014 Aug; 9(8):1677-82. PubMed ID: 24692176 [TBL] [Abstract][Full Text] [Related]
4. How dopamine transporter interacts with dopamine: insights from molecular modeling and simulation. Huang X; Zhan CG Biophys J; 2007 Nov; 93(10):3627-39. PubMed ID: 17704152 [TBL] [Abstract][Full Text] [Related]
5. Understanding G Protein Selectivity of Muscarinic Acetylcholine Receptors Using Computational Methods. Santiago LJ; Abrol R Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31653051 [TBL] [Abstract][Full Text] [Related]
6. Muscarinic acetylcholine receptor (mAChR) inhibitor from snake venom: interaction with subtypes of human mAChR. Miyoshi S; Tu AT Arch Biochem Biophys; 1999 Sep; 369(1):114-8. PubMed ID: 10462446 [TBL] [Abstract][Full Text] [Related]
7. A novel identification approach for discovery of 5-HydroxyTriptamine 2A antagonists: combination of 2D/3D similarity screening, molecular docking and molecular dynamics. Kumar R; Jade D; Gupta D J Biomol Struct Dyn; 2019 Mar; 37(4):931-943. PubMed ID: 29468945 [TBL] [Abstract][Full Text] [Related]
8. Crystal structure of the M Vuckovic Z; Gentry PR; Berizzi AE; Hirata K; Varghese S; Thompson G; van der Westhuizen ET; Burger WAC; Rahmani R; Valant C; Langmead CJ; Lindsley CW; Baell JB; Tobin AB; Sexton PM; Christopoulos A; Thal DM Proc Natl Acad Sci U S A; 2019 Dec; 116(51):26001-26007. PubMed ID: 31772027 [TBL] [Abstract][Full Text] [Related]
9. Three-dimensional models of histamine H3 receptor antagonist complexes and their pharmacophore. Axe FU; Bembenek SD; Szalma S J Mol Graph Model; 2006 May; 24(6):456-64. PubMed ID: 16386444 [TBL] [Abstract][Full Text] [Related]
10. Elucidation of conformational states, dynamics, and mechanism of binding in human κ-opioid receptor complexes. Leonis G; Avramopoulos A; Salmas RE; Durdagi S; Yurtsever M; Papadopoulos MG J Chem Inf Model; 2014 Aug; 54(8):2294-308. PubMed ID: 25060329 [TBL] [Abstract][Full Text] [Related]
11. Structural modifications to tetrahydropyridine-3-carboxylate esters en route to the discovery of M5-preferring muscarinic receptor orthosteric antagonists. Zheng G; Smith AM; Huang X; Subramanian KL; Siripurapu KB; Deaciuc A; Zhan CG; Dwoskin LP J Med Chem; 2013 Feb; 56(4):1693-703. PubMed ID: 23379472 [TBL] [Abstract][Full Text] [Related]
12. Imidacloprid and thiacloprid neonicotinoids bind more favourably to cockroach than to honeybee α6 nicotinic acetylcholine receptor: insights from computational studies. Selvam B; Graton J; Laurent AD; Alamiddine Z; Mathé-Allainmat M; Lebreton J; Coqueret O; Olivier C; Thany SH; Le Questel JY J Mol Graph Model; 2015 Feb; 55():1-12. PubMed ID: 25424654 [TBL] [Abstract][Full Text] [Related]
13. Structural determinants for the interactions between muscarinic toxin 7 and muscarinic acetylcholine receptors. Xu J; Zhao H; Zheng Z; Wang Y; Niu Y; Wang H; Xu J; Lu Y; Chen H J Mol Recognit; 2015 Apr; 28(4):239-52. PubMed ID: 25683330 [TBL] [Abstract][Full Text] [Related]
14. Development of VU6036864: A Triazolopyridine-Based High-Quality Antagonist Tool Compound of the M Li J; Orsi DL; Engers JL; Long MF; Capstick RA; Maurer MA; Presley CC; Vinson PN; Rodriguez AL; Han A; Cho HP; Chang S; Jackson M; Bubser M; Blobaum AL; Boutaud O; Nader MA; Niswender CM; Conn PJ; Jones CK; Lindsley CW; Han C J Med Chem; 2024 Aug; 67(16):14394-14413. PubMed ID: 39105778 [TBL] [Abstract][Full Text] [Related]
15. Molecular Mechanisms of Action of M5 Muscarinic Acetylcholine Receptor Allosteric Modulators. Berizzi AE; Gentry PR; Rueda P; Den Hoedt S; Sexton PM; Langmead CJ; Christopoulos A Mol Pharmacol; 2016 Oct; 90(4):427-36. PubMed ID: 27461343 [TBL] [Abstract][Full Text] [Related]
16. Molecular modeling and molecular dynamics simulation of the human A2B adenosine receptor. The study of the possible binding modes of the A2B receptor antagonists. Ivanov AA; Baskin II; Palyulin VA; Piccagli L; Baraldi PG; Zefirov NS J Med Chem; 2005 Nov; 48(22):6813-20. PubMed ID: 16250640 [TBL] [Abstract][Full Text] [Related]
17. Persistent binding and functional antagonism by xanomeline at the muscarinic M5 receptor. Grant MK; El-Fakahany EE J Pharmacol Exp Ther; 2005 Oct; 315(1):313-9. PubMed ID: 16002459 [TBL] [Abstract][Full Text] [Related]
18. Anchoring of a monotopic membrane protein: the binding of prostaglandin H2 synthase-1 to the surface of a phospholipid bilayer. Nina M; Bernèche S; Roux B Eur Biophys J; 2000; 29(6):439-54. PubMed ID: 11081405 [TBL] [Abstract][Full Text] [Related]
19. Modeling subtype-selective agonists binding with alpha4beta2 and alpha7 nicotinic acetylcholine receptors: effects of local binding and long-range electrostatic interactions. Huang X; Zheng F; Chen X; Crooks PA; Dwoskin LP; Zhan CG J Med Chem; 2006 Dec; 49(26):7661-74. PubMed ID: 17181149 [TBL] [Abstract][Full Text] [Related]
20. Deciphering the GPER/GPR30-agonist and antagonists interactions using molecular modeling studies, molecular dynamics, and docking simulations. Méndez-Luna D; Martínez-Archundia M; Maroun RC; Ceballos-Reyes G; Fragoso-Vázquez MJ; González-Juárez DE; Correa-Basurto J J Biomol Struct Dyn; 2015; 33(10):2161-72. PubMed ID: 25587872 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]